Searched for
DRUG ADVERTISING REGULATIONS
FDA issues compliance order for milk sector in Maharashtra; warns of Rs 10 lakh fine for violationsMaharashtra FDA has mandated strict food safety compliance across the entire milk supply chain, from farms to retailers. New guidelines aim...- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Why do people smoke? The psychology, science and social reasons say those who smoke despite knowing the health risks aren't just chasing nicotine, they may be seeking...Why do people smoke despite knowing the health risks? Explore the science, psychology and social factors behind smoking addiction, and nico...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- Offshore betting ads growing despite ban on online money games: ASCIOffshore betting promotions are proliferating across India, despite the government's crackdown on online gambling and its related advertise...
- Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarityEli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...
- Weight-loss drug craze for Ozempic, Mounjaro surges in India amid safety concernsIn India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...
- Regulator steps up oversight of GLP-1 drug distribution chainIndia's drug regulatory body is intensifying its scrutiny of the distribution channels for GLP-1 weight loss drugs. State drug authorities ...
- Govt cautions pharma cos against surrogate ads for promoting GLP-1 drugsWeight loss drug risks: The government has warned of strict regulatory action against those found using surrogate advertising to promote GL...
- India warns drugmakers against direct or surrogate weight-loss drug and obesity adsIndia's drug regulator has issued a stern warning to pharmaceutical companies. Direct or indirect advertising of weight-loss medicines is n...
- US FDA stepping up enforcement of pharma ad rules, sends letters to companiesThe Trump administration is intensifying its scrutiny of pharmaceutical advertising, with the FDA set to issue cease-and-desist notices and...
- Preventing misleading claims: Ads for diabetes, oncology drugs may need approvalThe government is looking to regulate advertisements for anti-diabetes, sex hormone, and oncology drugs by amending the Drugs and Cosmetics...
- Prevent Pandemic Profiteering, ProntoThe infectious nature of the disease, the rapidly mutating virus, the absence of a cure and the lack of firm answers since experts are stil...
- India to formulate advertising codeRecently, the Advertising Standards Council of India (ASCI), a voluntary self-regulatory organisation found 50 ad campaigns by ayurveda and...
- Government to come up with list of over-the-counter drugs soonThe move is aimed at promoting self-care & reducing cost of treatment without compromising patient safety.
- HC asks Centre, Maharashtra to list steps taken to regulate onlineThe directions came while the bench was hearing a Public Interest Litigation seeking that the government tackle illegal sale of 'Schedule H...
- Quality concern in herbal medicine remains a challenge: AYUSH MinisterHis remarks came amid a row over advertisement of ayurvedic formulation AYUSH-82 which claimed to treat diabetes.
- Doctors give drugs without knowing side-effects: StudyMost doctors depend on advertisements in medical journals or direct marketing by representatives to gather information about new medication...
- Pharma cos oppose DCGI's ban on emergency contraceptive pill adsCos say the move contradicts government's health policies besides hurting their investments.
Load More
